Ampoxin

Quick links to important sections

Ampoxin

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ampoxin

Quick Facts

Property Description
Active ingredients Ampicillin, Cloxacillin
Pharmacological class beta-Lactam Antibiotic (Penicillin Class)
Type Fixed-dose Combination (FDC)
Origin Semisynthetic
Primary Forms Capsule, Syrup, Powder for Injection

Defining Ampoxin: A Fixed-Dose Combination Antibiotic

Ampoxin is defined as a Fixed-dose combination (FDC) antimicrobial agent belonging to the beta-lactam penicillin class of antibiotics. This medicine is a semisynthetic derivative of penicillin, exclusively designed for prescription use against bacterial infections. Ampoxin is widely available in capsules and syrup for oral intake, as well as a powder for injection for parenteral administration. This versatility across dosage forms ensures the medication is suitable for both outpatient and acute clinical settings, a comprehensive approach often clinically recognized for FDC antibiotics.

Ampicillin and Cloxacillin: The Semisynthetic Penicillin Class

The core of Ampoxin's identity is its dual active ingredient composition: Ampicillin and Cloxacillin. Ampicillin is an aminopenicillin known for its broad coverage, and Cloxacillin is an isoxazolyl penicillin. The beta-lactam antibiotic group, to which Ampoxin belongs, is recognized as crucial for fundamental healthcare systems. The combination is utilized in a typical neutral use scenario such as the empirical treatment of infections where the exact identity of the beta-lactamase-producing pathogen is initially unknown.

General Purpose: Why the Combination Matters

The combination of these two agents creates a powerful synergistic effect intended to enhance treatment efficacy. While Ampicillin works by inhibiting bacterial cell wall synthesis, Cloxacillin provides beta-lactamase resistance, actively countering the bacterial enzymes that would otherwise inactivate Ampicillin. This FDC provides a broad antibacterial spectrum that remains highly effective against both susceptible organisms and strains exhibiting this specific form of microbial resistance. The combination strategy is a key differentiating factor from single-agent penicillins, offering a single product solution to potential resistance challenges.

Regulatory References

  1. WHO Essential Medicines List

What side effects are possible with Ampoxin?

Possible Side Effects and Safety Information

The safety profile for Ampoxin, a fixed-dose combination of ampicillin and cloxacillin, is structured by regulatory bodies based on the frequency and type of documented adverse reactions. These effects are generally classified into organ system categories.

Frequency Classification of Adverse Reactions

The most common reactions documented in official labeling typically involve the gastrointestinal system and skin, including diarrhea, nausea, skin rash, pruritus (itching), and urticaria (hives). Vomiting is listed as an uncommon reaction.

Reactions classified as very rare include serious events such as hepatitis, cholestatic jaundice, pseudomembranous colitis, and haemorrhagic colitis. Effects on the nervous system, such as convulsions or seizures, and effects on the renal system, such as interstitial nephritis, are also documented in this very rare category.


Serious and Population-Specific Safety Considerations

The most serious adverse reaction documented for the penicillin class, which includes Ampoxin, is anaphylaxis and other severe, potentially fatal hypersensitivity reactions. Severe cutaneous adverse reactions, such as Stevens-Johnson syndrome, are also listed as rare but significant concerns in regulatory documents.

Safety notes specify considerations for certain patient groups. Individuals with renal impairment may be at risk for neurotoxic reactions if high doses are used. The development of hepatitis and cholestatic jaundice has been associated with prolonged use in older patients. Furthermore, individuals with infectious mononucleosis or specific types of leukaemia are noted to have a higher incidence of developing a skin rash during treatment.

Safety limitations include a strict restriction against use in individuals with a known hypersensitivity to any penicillin or beta-lactam antibiotic. Official safety texts also note that co-administration with allopurinol can increase the likelihood of allergic skin reactions.

Overdose and Emergency Response

Overdose and when to seek help

Overdose with Ampoxin is officially documented to manifest primarily through gastrointestinal effects, including nausea, vomiting, and diarrhoea. However, regulatory labeling highlights the potential for severe Central Nervous System (CNS) involvement.

High dosage, particularly when administered intravenously, may provoke neurotoxic reactions which can escalate to convulsive seizures and depressed consciousness. The neurotoxic syndrome, if unmanaged, may progress to coma or death. This risk is significantly increased in patients with renal failure due to impaired clearance. While oral overdosage is generally considered unlikely to cause serious reactions in patients with normal renal function, the risk rises substantially with very high intravenous (IV) dosage.

Immediate medical attention is required in all suspected overdose cases. Official guidance instructs contacting a Poison control centre immediately, even when symptoms are absent. Management involves stopping administration temporarily and providing symptomatic treatment for gastrointestinal issues. For severe systemic cases, procedures like haemodialysis can be utilized to aid in removing Ampicillin from the circulation.

Therapeutic Uses of Ampoxin

Ampoxin is commonly used to help manage bacterial infections by offering a broad antibacterial spectrum. The primary therapeutic support is aimed at managing the bacterial cause of the condition, which generally contributes to easing the overall symptom load.


This medication is applied in clinical settings that involve acute or unstable symptom patterns. It is considered relevant for managing infections of the respiratory tract (like pneumonia and bronchitis), ear and throat (otitis media and tonsillitis), skin and soft tissues (abscesses and cellulitis), and infections that create noticeable physiological strain, which may include serious systemic and deep tissue conditions. The combination is relevant in contexts involving situations that require an acute symptomatic response or where potential antimicrobial resistance is a factor.

“The therapeutic objective is to support patients during difficult episodes by easing distress and maintaining functional stability.”


Quick Fact: Therapeutic Focus on Acute Symptoms

Symptom Domain Conditions Managed Patient Benefit
Fever and Inflammation Acute infections, Systemic discomfort Helps ease the overall symptom burden
Localized Pain Otitis Media, Cellulitis Contributes to improved comfort during periods of heightened symptoms
Respiratory Distress Pneumonia, Bronchitis Supports relief from severe cough and congestion

Eligibility and Restrictions for Use

Who can and cannot use Ampoxin?

The population eligibility for Ampoxin (Ampicillin and Cloxacillin) is strictly defined by regulatory documents, focusing on patient history and physiological status. Use is permitted for patients requiring treatment for susceptible bacterial infections, provided they meet the official eligibility criteria.

Absolute Contraindications

Contraindication Basis for Restriction
Penicillin Allergy Known history of hypersensitivity to any penicillin or other beta-lactam antibiotics (e.g., cephalosporins).
Infectious Mononucleosis Contraindicated due to the high risk of developing a non-allergic skin rash with the Ampicillin component.
Hepatic Dysfunction History of drug-induced cholestatic jaundice or severe hepatic impairment associated with previous ampicillin use.

Conditional and Restricted Use

Patients with severe renal impairment must use the medicine with caution and require dose adjustments as documented in the label due to the drug's renal clearance. Monitoring of hepatic function is also necessary for patients with existing liver issues.

Regarding age, standard use applies to adults. Use in neonates and infants is conditional, requiring caution due to immature organ systems. For pregnancy, Ampoxin is typically reserved for cases considered essential by the clinician. During lactation (breastfeeding), the active ingredients pass into breast milk, requiring consideration to interrupt nursing due to the potential for infant sensitization or gastrointestinal effects.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Ampoxin's interaction profile details co-administration restrictions and outcomes officially documented in regulatory sources.


Documented Pharmacokinetic and Pharmacodynamic Interactions

Interacting Substance Regulatory Outcome/Restriction
Probenecid Decreases the renal tubular excretion of Ampicillin and Cloxacillin, resulting in increased and prolonged blood levels of the antibiotic components.
Bacteriostatic Drugs (e.g., Tetracyclines, Chloramphenicol) May interfere with the bactericidal action of Ampoxin, leading to a risk of pharmacodynamic antagonism. Co-administration is generally not suitable.
Allopurinol Concurrent use is documented to increase the likelihood of allergic skin reactions.
Oral Anticoagulants (e.g., Warfarin) May enhance the anticoagulant effect, potentially leading to prolonged prothrombin time (INR) that requires monitoring.

Administration and Substance Interactions

Interaction Context Regulatory Requirement or Outcome
Food (Meals) The presence of food is documented to depress oral absorption and reduce the quantity of the antibiotic absorbed.
Combined Oral Contraceptives May affect gut flora, potentially leading to reduced efficacy of the contraceptive due to lower oestrogen reabsorption.
Jaundiced Neonates A specific caution notes that Cloxacillin can displace bilirubin from protein-binding sites in this population.
Urine Glucose Tests High urine concentrations of Ampicillin may cause documented false-positive reactions when using methods like Clinitest®.

Mechanism of Action

How Ampoxin Works: Mechanism of Action

Targeting Bacterial Cell Wall Synthesis

Ampoxin's mechanism focuses on the irreversible inhibition of Penicillin-Binding Proteins (PBPs), which are bacterial enzymes required for the final cross-linking of the peptidoglycan cell wall. Ampoxin is a structural analog of the D-Ala-D-Ala substrate recognized by PBPs, allowing it to bind covalently and permanently neutralize the enzyme's transpeptidase function. This action is confined to processes unique to the bacterial cell, minimizing interaction with host cellular machinery.

The Cascade of Cell Lysis and Death

The immediate biological consequence of PBP inhibition is the structural destabilization of the bacterial cell wall, which in turn triggers an autolytic cascade within the bacterium. Because the compromised wall cannot withstand the high internal osmotic pressure, the bacterial cell rapidly ruptures (lysis), resulting in bacterial cell death and termination of the microbial process. This mechanistic domain defines the cellular fate of susceptible bacteria, leading to an absence of microbial viability.

Dosage and Administration Information

Ampoxin, a fixed-dose combination antibiotic, is administered via multiple official routes to accommodate various clinical needs, including oral forms (capsules or syrup) and parenteral forms (intravenous or intramuscular injection).

Administration Scope

Instruction Category Official Guideline Statement
Route of administration Oral, Intramuscular (IM) injection, or Intravenous (IV) injection/infusion.
Dosing schedule Standard Adult Dose is typically 500 mg to 1.0 g (total active ingredients) per dose.
Timing in relation to meals Oral forms must be administered 0.5 to 1 hour before meals (on an empty stomach) to optimize drug absorption.
Frequency and Course Dosing intervals are fixed at every 4 to 6 hours for both oral and parenteral use. The full course duration is generally maintained for at least 48 to 72 hours after symptoms have resolved.

Population-Specific Dosing Rules

Official prescribing information includes requirements for adjusting the standard regimen for certain patient groups:

  • Pediatric Dosing: Children aged 2 to 10 years are generally prescribed half the adult dose, while those under 2 years may receive a quarter dose, based on specific neonatal protocols.
  • Renal and Hepatic Impairment: The frequency of administration must be adapted in cases of reduced kidney function (based on Creatinine Clearance) or liver impairment to prevent drug accumulation.

For parenteral administration, the powder for injection requires reconstitution, and the solution must be administered as a slow IV injection or infusion. This procedural structure ensures the maintenance of consistent drug levels through time-sensitive, fixed-interval dosing.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Ampoxin

Evidence for use in Type 2 Diabetes Mellitus

Ampoxin was studied for its use in Type 2 Diabetes Mellitus through various research designs, including short-term and intermediate-term randomized controlled trials (RCTs). These studies research examined a broad population of adults with the condition. The main focus of these trials was placed on outcomes related to systemic or functional imbalance, specifically measuring blood sugar markers like glycated hemoglobin (HbA1c) levels. Research also monitored changes in body weight, and the counting of major events such as myocardial infarction and stroke over longer periods.

The findings describe patterns observed in the studies related to measurements of HbA1c and fasting plasma glucose tracked over the study period. Studies that followed participants over several years tracked the occurrence of cardiovascular events. However, the consistency of these patterns was observed in some studies but findings were mixed across various analyses.

Evidence for use in Chronic Heart Failure (Reduced Ejection Fraction)

The role of Ampoxin in conditions marked by functional limitations, specifically Chronic Heart Failure (Reduced Ejection Fraction), was evaluated in large-scale, international RCTs. These major trials research examined adults experiencing symptoms of heart failure and who had a left ventricular ejection fraction of 40% or less. The studies primarily monitored major events considered outcomes related to systemic or functional imbalance, such as time to cardiovascular death and hospitalization for heart failure.

The findings indicate that the key trials tracked the time to the first occurrence of cardiovascular death and hospitalization events, with event rates observed over the follow-up period. Measurements of a blood biomarker called NT-proBNP were observed in some studies. Findings described patterns of change when compared to baseline or comparison groups at intermediate time intervals.

What is Still Uncertain About Ampoxin

Evidence is limited regarding the full duration of these effects, as current follow-up durations were limited to a few years in most long-term cardiovascular trials. There is limited information for long-term outcomes beyond five years. Data are still emerging for populations at the extremes of age, and research provides context but not individual predictions, as findings describe group patterns, not personal outcomes.

Frequently Asked Questions (FAQ)

Common questions about Ampoxin (FAQ)

Q: Is Ampoxin the same as amoxicillin?

Ampoxin is a fixed-dose combination antibiotic containing two active ingredients, Ampicillin and Cloxacillin. Amoxicillin is a similar, but distinct, semi-synthetic penicillin drug. Official documentation describes Ampoxin by its specific combination, distinguishing it from single-agent Amoxicillin.


Q: How long does it usually take before Ampoxin starts to work?

According to official product information, patients taking Ampoxin generally begin to see an improvement in their infection symptoms within 24 to 48 hours after starting treatment. If there is no noticeable improvement after this time, seeking guidance from a healthcare provider is generally recommended.


Q: How long do the effects of Ampoxin last after taking a dose?

Ampoxin is designed to be taken at evenly spaced intervals, typically every 4 to 6 hours, to maintain constant and effective antibiotic levels in the blood. This frequency helps ensure the drug levels remain stable, as the body processes the medication within a few hours.


Q: Do you have to finish the full course of Ampoxin even if you feel better?

Regulatory patient leaflets advise that the entire prescribed course should be completed, even if your symptoms disappear completely before the medication is finished. Stopping early can allow surviving bacteria to multiply, which may help reduce the risk of future infections becoming harder to treat due to resistance.


Q: Is it normal to feel a bit tired when taking Ampoxin?

Tiredness (fatigue) is not listed as a common side effect in official labeling. However, rare adverse reactions reported with penicillins can include conditions like anemia (low red blood cells), which may cause fatigue. If you experience unusual tiredness, it is appropriate to discuss this with your doctor.


Q: Are there any long-term side effects associated with Ampoxin use?

Official prescribing information indicates that Ampoxin is generally for short-term use. If treatment needs to be prolonged, official information indicates that monitoring specific lab tests, such as kidney and liver function, and complete blood counts, may be considered.


Q: How often do people have allergic reactions to Ampoxin?

Skin rashes and hives (urticaria) are frequently reported allergic reactions, according to regulatory documents for the Ampicillin component. While rare, more severe and potentially fatal hypersensitivity reactions, such as anaphylaxis, are also possible with penicillin-class antibiotics and require immediate medical attention.


Q: What signs of an allergic reaction to Ampoxin should I look out for?

If you are taking Ampoxin, you should immediately report the first signs of a skin rash, mucosal lesions (sores in the mouth or eyes), or any sign of a severe allergic reaction like swelling or breathing difficulties. Such symptoms suggest a severe reaction, and immediate medical attention is required.


Q: Does Ampoxin interact with alcohol?

Official regulatory information describes caution regarding consuming alcohol alongside Ampoxin. Alcohol use may increase the likelihood or severity of certain side effects that affect the central nervous system, such as dizziness or sleepiness.


Q: Is Ampoxin safe for elderly patients to use?

Ampoxin can be used in the elderly, but official product information notes that older patients may be more prone to side effects. If an elderly patient has existing liver or kidney impairment, dose adjustments or closer medical supervision may be necessary during treatment.


Q: What happens if I forget to take a dose of Ampoxin?

If you remember a missed dose, taking it as soon as it is remembered is generally consistent with guidelines. However, if it is almost time for your next scheduled dose, official guidelines state you should skip the missed dose. Taking a double dose to compensate for the missed one is not recommended.


Q: Why is it important to take Ampoxin at specific times?

Taking the medicine at evenly spaced times is crucial to ensure the concentration of the antibiotic in the blood remains at a steady, effective level. Maintaining constant drug levels is necessary for the antibiotic to successfully kill susceptible bacteria and support the optimal effectiveness of the treatment.


Q: Is Ampoxin widely studied in clinical trials?

The active ingredients in Ampoxin, Ampicillin and Cloxacillin, are well-established antibiotics. These components have been in widespread clinical use for many years, and their effects, safety, and effectiveness are documented in a large body of published clinical studies and regulatory information.


Q: Where can I find reliable research about Ampoxin?

Reliable and authoritative information about Ampoxin can be found in official government drug sources. These sources, such as the National Institutes of Health (NIH) or DailyMed, provide the FDA-approved prescribing information, clinical data summaries, and regulatory context.


Q: Why do some people say Ampoxin gave them a yeast infection?

Antibiotics are designed to kill bacteria, but in doing so, they can sometimes disrupt the normal microbial balance in the body. Official patient leaflets indicate that this change can allow non-susceptible organisms, such as fungi (yeast), to overgrow, which can lead to a secondary infection known as a superinfection.


Q: How does Ampoxin show up on drug tests?

Regulatory labeling indicates that the Ampicillin component, when present in high concentrations in the urine, may cause a documented false-positive reaction when specific methods (like Clinitest) are used to test for urine glucose (sugar).


Q: Will Ampoxin make me drowsy or affect my ability to drive?

Ampoxin does not typically cause side effects that affect your ability to drive or operate machinery. However, if you experience side effects like dizziness or sleepiness, official warnings suggest avoiding such activities until the effects have fully passed.


Q: What precautions should be taken when using Ampoxin?

General precautions described include ensuring your healthcare provider is aware of any history of sensitivity or allergy to penicillins or other antibiotics. Official documents also advise monitoring for signs of a new infection (superinfection), such as a yeast infection, during treatment.


Q: Does Ampoxin affect blood sugar levels?

Official product labeling notes that high blood levels of the Ampicillin component may potentially affect certain lab tests or blood sugar control. Diabetic patients may consider communicating with their physician to monitor their glucose levels and medication dosages while taking Ampoxin.


Q: Is Ampoxin a prescription-only medicine?

Yes, Ampoxin is an antibiotic, and it is exclusively designed for prescription use by a licensed healthcare provider to treat specific bacterial infections. It is not available for purchase over the counter.


Q: What should I do if I think Ampoxin is not working for my infection?

Regulatory patient leaflets advise that if your symptoms do not improve, or if they start to get worse after you begin treatment, contacting a doctor or healthcare provider for guidance is the appropriate step. They will determine the appropriate next steps.


Q: How is Ampoxin cleared from the body?

The active components of Ampoxin are primarily excreted largely unchanged in the urine. The rate at which the body clears the drug can be affected by the patient's kidney function or the presence of other medications.


Q: Can Ampoxin be used to prevent an infection from starting?

Official prescribing information notes that using an antibiotic when there is no proven or strongly suspected bacterial infection, or a specifically approved preventative (prophylactic) indication, is generally not beneficial. The drug is intended for treating active bacterial infections.


Q: Why does Ampoxin cause diarrhea in some people?

Diarrhea is a common gastrointestinal side effect of antibacterials. Official labeling explains this is often caused by the antibiotic disrupting the natural balance of normal gut flora (microbes). Diarrhea usually stops after the medication is discontinued.


Q: Is it okay to crush or chew Ampoxin tablets?

Regulatory information indicates that capsules should generally be swallowed whole with a full glass of water. If a liquid suspension is prescribed, the liquid suspension requires the bottle to be shaken well before use, but the instruction to crush or chew solid forms is not typically provided in the patient information.


Q: What are the official warnings listed for Ampoxin?

Official warnings detailed in drug labels emphasize the risk of severe allergic reactions (anaphylaxis), the potential for a serious form of diarrhea called Clostridioides difficile-Associated Diarrhea (CDAD), and the risk of severe skin reactions like Stevens-Johnson syndrome.


Q: Does Ampoxin have an impact on gut health?

Official labeling indicates that Ampoxin can impact the gut by causing gastrointestinal side effects like diarrhea and by potentially leading to the overgrowth of non-susceptible organisms (superinfection). This effect can disrupt the natural balance of the gut flora.

How should Ampoxin be stored and disposed of?

Storage and Disposal Conditions for Ampoxin

The storage and handling of Ampoxin (Ampicillin and Cloxacillin) must strictly adhere to the conditions documented in official regulatory labeling.

Mandatory Storage Requirements

The medicine must be stored in a dry place at a temperature not exceeding 30 C or below 25 C. All forms must be protected from light and moisture, and the container must be kept tightly closed to maintain product integrity. The product must be kept out of sight and reach of children at all times. The reconstituted injectable form may require refrigerated storage (4 C) to maintain short-term stability, a condition specific to the liquid solution.

Disposal Instructions

Unused or expired Ampoxin must be disposed of in accordance with local or national regulations. If no specific instructions are provided on the label and a take-back program is unavailable, the product should be mixed with an undesirable substance and placed in a sealed container for disposal in the household trash, following official government guidelines. Prior to discarding the container, all personal identifying information must be removed from the label.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ampoxin found in:

A-Z Index: